Supreme Court quashes drug supplier’s blacklisting over denial of retesting

The Supreme Court of India quashed the blacklisting and product debarment imposed on a drug supplier after authorities failed to follow the mandatory procedure for confirmatory testing by a second laboratory. The Court held that delays attributable to the State caused the disputed batches to expire, depriving the supplier of an effective opportunity to challenge the adverse quality reports through retesting.